Stay updated on Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial

Sign up to get notified when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant decrease in exacerbations and an increase in lung function and quality of life in patients with severe eosinophilic asthma due to benralizumab treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:18.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age range, health conditions, and treatment history required for inclusion in the study. Previously, this section had no information provided.
    Difference
    40%
    Check dated 2024-05-22T21:23:54.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:39:41.000Z thumbnail image

Stay in the know with updates to Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.